Madrigal Pharmaceuticals
MDGL
#2088
Rank
C$12.62 B
Marketcap
C$543.63
Share price
-4.45%
Change (1 day)
-30.56%
Change (1 year)

EPS for Madrigal Pharmaceuticals (MDGL)

EPS in 2026 (TTM): C-$8.16

According to Madrigal Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C-$8.47. In 2025 the company made an earnings per share (EPS) of C-$15.33 an increase over its 2024 EPS that were of C-$31.71.

EPS history for Madrigal Pharmaceuticals from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$8.16-46.77%
2025C-$15.33-51.65%
2024C-$31.71
2022C-$24.7117.93%
2021C-$20.9511.61%
2020C-$18.77140.18%
2019C-$7.82146.61%
2018C-$3.17-12.99%
2017C-$3.64-91.03%
2016C-$40.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
C-$0.27-96.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C-$1.36-83.93%๐Ÿ‡บ๐Ÿ‡ธ USA